| Name | Title | Contact Details |
|---|
Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company developing transformative therapeutics to address serious, progressive eye diseases that lead to blindness. Our lead compound, ALK-001, is an oral investigational drug being developed for the treatment of Stargardt disease (STGD) and Geographic Atrophy (GA) secondary to dry age-related macular degeneration. ALK-001 is a selectively-deuterated form of Vitamin A that slows the dimerization of Vitamin A, which is implicated in STGD, and has shown statistically-significant and clinically-meaningful efficacy in the TEASE-1 Phase 2 clinical trial. Based on these results, ALK-001 has been granted Breakthrough Therapy Designation for the treatment of Stargardt Disease.
Planthaven is a Santa Barbara, CA-based company in the Business Services sector.
Ultitek is a Englewood Cliffs, NJ-based company in the Business Services sector.
Cane River Surgery Center is a Natchitoches, LA-based company in the Business Services sector.
Newpark Drilling Fluids is the fastest growing fluids company in North America. We have grown since inception at an annual rate of more than 50%. What drives Newpark Drilling Fluids? Our focus on performance, technology and service. We are a fully